Skip to main content

Peer Review reports

From: SLC27A2 is a potential immune biomarker for hematological tumors and significantly regulates the cell cycle progression of diffuse large B-cell lymphoma

Original Submission
31 Oct 2023 Submitted Original manuscript
15 Nov 2023 Reviewed Reviewer Report
17 Feb 2024 Author responded Author comments - Hongxia Li
Resubmission - Version 2
17 Feb 2024 Submitted Manuscript version 2
21 Feb 2024 Author responded Author comments - Hongxia Li
Resubmission - Version 3
21 Feb 2024 Submitted Manuscript version 3
2 Mar 2024 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
27 Mar 2024 Editorially accepted
25 Apr 2024 Article published 10.1186/s12920-024-01853-3

You can find further information about peer review here.

Back to article page